Convening Notice of 6th Annual General Meeting

Pursuant to Article 365 of the Korean Commercial Act and Article 21 of the Articles of Incorporation of the Company, SCAI Therapeutics Co., Ltd. hereby announces that the 6th Annual General Meeting of Shareholders for the fiscal year January 1, 2024 – December 31, 2024 will be held as follows. Your attendance is kindly requested.

Details of the Meeting

1. Date and Time:
   Friday, March 28, 2025, at 10:00 a.m.

2. Venue:
   12th Floor, D&0 Gangnam Building, 2621 Nambusunhwan-ro, Gangnam-gu, Seoul, Republic of Korea

3. Agenda:

a. Reports:

• Business Report

• Audit Report

b. Proposals for Resolution:

1. Approval of the Financial Statements for the 6th Fiscal Year

2. Election of Internal Director

3. Election of Outside Director

4. Appointment of Auditor

5. Approval of the Limit for Directors’ Remuneration

6. Approval of the Limit for Auditors’ Remuneration

7. Approval for Granting Stock Options

c.Exercise of Voting Rights:

Shareholders may exercise their voting rights either in person at the meeting or by proxy in accordance with the power of attorney.

March 13, 2025
SCAI Therapeutics Co., Ltd.
Chief Executive Officer: Chul hwan Kim